Abstract:Objectives Our previous studies have shown that interleukin-6 (IL-6) is overexpressed in the saliva of patients with oral lichen planus (OLP) and is positively correlated with severity of disease. IL-6 may be associated with immune imbalance in patients with OLP. The purpose of the present study was to investigate the inhibitory effect of IL-6 on regulatory T cells (Treg) derived from patients with OLP. Study Design The diagnosis of OLP was acquired on the basis of both clinical and pathologic manifestations. Peripheral blood and its cultured supernatants were detected by using cytometric beads assay. The expression of IL-6 in local lesions was detected by using immunohistochemistry. The inhibition effect of OLP-derived or healthy-derived Treg on the proliferation of T effector cells (Teff) was detected by using flow cytometry; The OLP-derived Treg inhibition effect was detected after upregulating or neutralizing IL-6. Results Plasma IL-6 concentration in 31 patients with OLP was 10660.00 ± 7205.00 fg/mL, which was significantly higher than that in the healthy control group (325.70 ± 32.28 fg/mL; n = 11; P < .05). It was also higher in ex vivo cultured supernatants of patient-derived Teff than those of healthy controls (133.60 ± 30.01 μg/mL vs 34.94 ± 11.47 μg/mL; n = 6; P < .05). IL-6 was also overexpressed in local lesions than in healthy controls. In a co-culture experiment, the inhibition rate of OLP-derived Treg against proliferation of autologous Teff was 36.15% ± 4.78%, which was significantly lower than that in the healthy control group by 57.75% ± 6.68% (P < .05; n = 6). When IL-6 was added to healthy-derived Treg, the inhibition rate decreased to 32.92% ± 5.54%; after neutralizing IL-6 in OLP-derived Treg, the inhibition rate went up to 55.32% ± 5.13%. Conclusions IL-6 was elevated in peripheral blood and local lesions in patients with OLP. In vitro, the inhibition effect of Treg on proliferation of autologous Teff in patients with OLP was significantly lower than that in healthy controls. This phenotype could be reversed in vitro when neutralizing IL-6. IL-6 may be an important factor affecting the immune homeostasis in OLP. Our previous studies have shown that interleukin-6 (IL-6) is overexpressed in the saliva of patients with oral lichen planus (OLP) and is positively correlated with severity of disease. IL-6 may be associated with immune imbalance in patients with OLP. The purpose of the present study was to investigate the inhibitory effect of IL-6 on regulatory T cells (Treg) derived from patients with OLP. The diagnosis of OLP was acquired on the basis of both clinical and pathologic manifestations. Peripheral blood and its cultured supernatants were detected by using cytometric beads assay. The expression of IL-6 in local lesions was detected by using immunohistochemistry. The inhibition effect of OLP-derived or healthy-derived Treg on the proliferation of T effector cells (Teff) was detected by using flow cytometry; The OLP-derived Treg inhibition effect was detected after upregulating or neutralizing IL-6. Plasma IL-6 concentration in 31 patients with OLP was 10660.00 ± 7205.00 fg/mL, which was significantly higher than that in the healthy control group (325.70 ± 32.28 fg/mL; n = 11; P < .05). It was also higher in ex vivo cultured supernatants of patient-derived Teff than those of healthy controls (133.60 ± 30.01 μg/mL vs 34.94 ± 11.47 μg/mL; n = 6; P < .05). IL-6 was also overexpressed in local lesions than in healthy controls. In a co-culture experiment, the inhibition rate of OLP-derived Treg against proliferation of autologous Teff was 36.15% ± 4.78%, which was significantly lower than that in the healthy control group by 57.75% ± 6.68% (P < .05; n = 6). When IL-6 was added to healthy-derived Treg, the inhibition rate decreased to 32.92% ± 5.54%; after neutralizing IL-6 in OLP-derived Treg, the inhibition rate went up to 55.32% ± 5.13%. IL-6 was elevated in peripheral blood and local lesions in patients with OLP. In vitro, the inhibition effect of Treg on proliferation of autologous Teff in patients with OLP was significantly lower than that in healthy controls. This phenotype could be reversed in vitro when neutralizing IL-6. IL-6 may be an important factor affecting the immune homeostasis in OLP.

Elevated IL-10 Concentrations in Serum and Saliva from Patients with Oral Lichen Planus.

The relationship between the expression of IL-6,IL-10 in saliva and the activity of disease in patients with oral lichen planus

IFN-gamma and IL-4 in Saliva of Patients with Oral Lichen Planus: a Study in an Ethnic Chinese Population.

Interferon- γ and interleukin-4 detected in serum and saliva from patients with oral lichen planus

Salivary and Serum Interleukin-18 in Patients with Oral Lichen Planus: A Study in an Ethnic Chinese Population

NF-κB-dependent Cytokines in Saliva and Serum from Patients with Oral Lichen Planus: A Study in an Ethnic Chinese Population

Mixed and Inhomogeneous Expression Profile of Th1/Th2 Related Cytokines Detected by Cytometric Bead Array in the Saliva of Patients with Oral Lichen Planus.

Analysis of oral microbial community and Th17-associated cytokines in saliva of patients with oral lichen planus

Expression of Osteopontin and Other Cytokines in Saliva and Serum in Patients with Oral Lichen Planus

Expressions of IFN-γ and IL-10 in sub-epithelial connective tissues of oral lichen planus

Oral Lichen Planus May Enhance the Expression of Th17-Associated Cytokines in Local Lesions of Chronic Periodontitis

Overexpression and Selectively Regulatory Roles of IL-23/IL-17 Axis in the Lesions of Oral Lichen Planus

Salivary Cytokine Profile in Patients with Oral Lichen Planus

Overexpressed Interleukin-6 Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus: an in Vitro Study

Interaction Between Oral Lichen Planus and Chronic Periodontitis with Th17-Associated Cytokines in Serum

Association Between –1082 A/G Polymorphism in IL-10 and Oral Lichen Planus: A Meta-Analysis

Immunoexpression of Interleukin-22 and Interleukin-23 in Oral and Cutaneous Lichen Planus Lesions: a Preliminary Study.

[The Expression and Significance of Interleukin-35 Receptor in Oral Lichen Planus].

Structural Analysis of Salivary Bacterial and Fungal Microbiome in Oral Lichen Planus Patients

Increasing CCL5/CCR5 on CD4+ T Cells in Peripheral Blood of Oral Lichen Planus

Dynamic changes of Th1/Th2/Th17 cytokines and hBD-2/3 in erosive oral lichen planus patients saliva before and after prednisone acetate treatment